FluidForm Bio’s 3D bioprinting tech keeps lab-grown cells alive five times deeper using vascular-like gelatin scaffolds.

Increasing evidence highlights a bidirectional relationship between circadian disruption and hepatic pathophysiology, suggesting liver disease is both a consequence and a driver of circadian ...

Discover how individualised treatment for febrile UTIs lowers antibiotic use and reduces adverse events in children.

Final results from the RA-BEYOND study show that patients with rheumatoid arthritis can often maintain disease control after tapering baricitinib from 4 mg to 2 mg.

Findings presented at ESCMID Global 2025 highlight the potential of AI-enhanced ultrasound as a frontline diagnostic tool for tuberculosis.

Long-term data from the VISIONARY-MS Phase 2 trial links improved brain imaging and visual evoked potentials to remyelination and neuronal repair in MS patients treated with CNM-Au8.

A study shows that dentists can help identify early signs of childhood leukaemia through clinical and radiographical indicators, offering the potential for quicker diagnosis and improved outcomes.

A novel breath test that identifies bacterial infections may offer clinicians a rapid, non-invasive diagnostic and monitoring tool.

A national study highlights how electronic patient-reported outcomes (ePROs) are changing symptom management in metastatic cancer care—offering better communication and patient engagement, while also ...

An umbrella meta-analysis confirms that probiotic supplementation, especially multi-strain, lowers the risk of necrotising enterocolitis and related mortality in preterm infants.

MIGRAINE is a widespread neurological disorder affecting over a billion people globally, ranking as the second most debilitating health condition. Characterised by severe headaches that can last for ...

The UK government has formally signed into law new clinical trial regulations, designed to modernise operations across the ...